Overview Request Sample Pages Request Customization Download PDF
You are viewing: Japan Gene Expression Analysis Market analysis

The Japan Gene Expression Analysis Market was valued at $123 Million in 2026 and projected to reach to $184.7 Million by 2031, representing a compound annual growth rate of 8.5%. Japan's gene expression analysis market is positioned for sustained expansion through 2031, driven by the country's commitment to precision medicine and advanced diagnostics.

Japan Gene Expression Analysis Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Gene Expression Analysis Market Trends and Insights

  • Japan's advanced healthcare infrastructure and strong investment in precision medicine are driving adoption of gene expression technologies across diagnostic and research applications.
  • The country's aging population and rising prevalence of cancer and genetic disorders are accelerating demand for molecular diagnostics in Japan. Japan's market growth is supported by increasing collaboration between academic institutions and biotechnology firms, alongside government initiatives promoting genomic research.
  • Japan's regulatory environment continues to streamline approvals for molecular diagnostic platforms, enabling faster market entry.
  • By 2031, Japan is expected to solidify its position as a leading market for gene expression analysis in the Asia Pacific region, driven by technological innovation and clinical adoption..

Key Market Statistics

  • CAGR (2026-2031) 8.5% CAGR
  • Market Size, 2026 ~USD 123 Million
  • Forecast, 2031 ~USD 184.7 Million
  • Country Japan

Japan Gene Expression Analysis Market Overview

Market Valuation Growth :

Japan's gene expression analysis market is valued at $123.0 million in 2026 and is projected to reach $184.7 million by 2031, representing a robust 8.5% CAGR, outpacing the global average of 7%.

Advanced Healthcare Infrastructure :

Japan's state-of-the-art medical facilities and strong government support for precision medicine initiatives are accelerating the adoption of gene expression technologies in both clinical diagnostics and research settings.

Aging Population Dynamics :

With one of the world's oldest populations, Japan faces increasing demand for advanced diagnostic tools to address age-related diseases, particularly cancer, driving investment in gene expression analysis solutions.

Research & Development Leadership :

Japan's pharmaceutical and biotech sectors are leveraging gene expression analysis for drug development and personalized medicine, supported by substantial R&D funding and academic collaborations.

Japan Gene Expression Analysis Market Dynamics

  • The aging demographic profile necessitates innovative solutions for early disease detection and treatment optimization, particularly in oncology and cardiovascular applications.
  • Japan's robust healthcare reimbursement system and strong pharmaceutical industry presence create favorable conditions for technology adoption and market penetration. Key growth catalysts include increasing clinical laboratory automation, rising cancer incidence rates, and growing integration of gene expression profiling in treatment decision-making.
  • Strategic partnerships between Japanese healthcare providers and international biotech firms, combined with government initiatives supporting genomic research, will further accelerate market development.
  • The market is expected to benefit from technological advancements in sequencing platforms and bioinformatics tools tailored to Japanese healthcare standards..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • Japan's gene expression analysis market is valued at $123.0 million in 2026 and is forecast to reach $184.7 million by 2031, representing an 8.5% CAGR.
      • Japan's aging population and high cancer incidence are primary drivers of demand for gene expression diagnostic solutions.
      • Japan's strong healthcare infrastructure and government support for genomic research create favorable conditions for market expansion.
      • Japan is positioned as a key growth market in Asia Pacific, with increasing adoption of precision medicine and molecular diagnostics.

      Gene Expression Analysis Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment ASSAYS & KITS (Type)
      Forecast Period 2026–2031
      Growth Rate CAGR of 7% from 2026 to 2031
      Largest Segment REAGENTS & CONSUMABLES (Offering)
      Market Size Base Year (Billions) ~USD 4.23 (2026)
      Revenue Forecast (Billions) ~USD 5.93 (2031)
      Segments Covered Offering, Type

      Japan Gene Expression Analysis Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Offering

      • Instruments
      • Reagents & Consumables
      • Software & Services

      By Type

      • Assays & Kits
      • Bioinformatics & Data Analysis Services
      • Bioinformatics Solutions
      • Cdna Synthesis Kits
      • Cloud-Based Analysis Platforms
      • Data Analysis Software & Visualization Tools
      • Dna Chips
      • Dna Microarray Scanners
      • Enzymes
      • Gene Expression Analysis
      • Gene Expression Databases
      • Library Preparation Kits
      • Microarray Analysis Services
      • Ngs Instruments
      • Other Assays & Kits
      • Other Gene Expression Services
      • Other Instruments
      • Other Reagents & Consumables
      • Pcr Assays & Kits
      • Pcr Instruments
      • Qpcr Profiling Services
      • Rna Isolation Kits
      • Rna Sequencing Services
      • Software

      JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      ACADEMIC & RESEARCH INSTITUTES3435.938.240.843.847.150.955.27.7
      CROS23.424.926.82931.434.137.240.88.7
      HOSPITALS & CLINICAL LABORATORIES31.333.536.239.242.646.551569.1
      OTHER END USERS8.18.28.38.58.68.88.99.11.7
      PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES58.461.966.271.276.883.190.398.58.3
      TOTAL155.3164.4175.7188.8203.2219.6238.2259.58.1

      Target Audience

      • Pharmaceutical & Biotech Companies : Japanese and international pharma firms need Japan-specific market data to guide R&D investments, clinical trial planning, and commercialization strategies for gene expression-based diagnostics and therapeutics.
      • Diagnostic Laboratory Operators : Clinical and research laboratories in Japan require market insights to assess technology adoption opportunities, competitive positioning, and investment priorities in gene expression analysis capabilities.
      • Healthcare System Administrators : Japanese hospital networks and healthcare providers need market intelligence to evaluate precision medicine integration, budget allocation for genomic testing, and technology procurement decisions.
      • Medical Device & Equipment Manufacturers : Equipment suppliers targeting Japan's healthcare sector require market data to identify demand trends, regulatory pathways, and partnership opportunities for gene expression analysis platforms.
      • Investment & Venture Capital Firms : Investors evaluating opportunities in Japan's biotech and healthcare sectors need comprehensive market analysis to assess growth potential, competitive dynamics, and risk factors in gene expression analysis.

      Key Companies in the Japan Gene Expression Analysis Market

      CompanyHQOwnershipStrongest segments
      ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation services,Software and digital factory solutions,
      DECODE GENETICSIcelandPrivate CompanyInternal Amgen discovery and target validation programs,External research collaborations and grants,Commercial genomics and analytics services,
      GENOMIC HEALTH INCUnited StatesPrivate CompanyOncotype DX Breast Recurrence Score and related breast assays,Oncotype DX Colon and other solid tumor assays,Emerging decision-support and ancillary genomic services,
      TRANSGENOMIC, INC.United StatesPublic CompanyGenetic analytical and pharmacogenomics research services,Multiplexed ICE COLD-PCR reagents and consumables,Other genomic testing and platform technologies (ICE COLD-PCR, cfDNA, CTC assays),
      UNILABSSwitzerlandPrivate CompanyRoutine & specialised laboratory testing,Medical imaging,Pathology & centres of excellence,
      MAXCYTE, INCUnited StatesPublic CompanyExPERT instruments (ATx, STx, GTx, VLx),Processing assemblies (PAs) and consumables,Licensing and technology access fees,
      GENERAL ELECTRICUnited StatesPublic CompanyCommercial Engines & Services,Defense & Propulsion Technologies,Aircraft Components and Systems (Avio Aero, Unison, Dowty, Colibrium Additive),
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyLife Science segment,Clinical Diagnostics segment,
      ILLUMINA, INC.United StatesPublic CompanySequencing instruments,Sequencing consumables (reagents, flow cells, library prep),Array-based instruments and consumables,
      QIAGENNetherlandsPublic CompanySample technology consumables and instruments,Molecular diagnostics assays (immune response, oncology, sexual and reproductive health),Research PCR and enzymes (qPCR, digital PCR, RT-PCR),
      REVVITYUnited StatesPublic CompanyDiagnostics (prenatal, neonatal, infectious disease, immunodiagnostics),Life Science Reagents & Assays (BioLegend, Dharmacon, AlphaLISA, etc.),Instruments & Imaging Systems,
      PACBIOUnited StatesPublic CompanyLong-read instruments (Revio, Sequel, Vega),Long-read consumables (SMRT cells, library prep, binding and sequencing kits),Short-read (Onso platform and reagents),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      SYSMEX CORPORATIONJapanPublic CompanyHematology analyzers and reagents (XN-Series, XN-V, ProCyte Dx),Coagulation diagnostics,Blood gas, electrolyte, and urinalysis systems,
      EUROFINS SCIENTIFICLuxembourgPublic CompanyFood and Feed Testing,Environment Testing,Biopharma Services,
      STANDARD BIOTOOLSUnited StatesPublic CompanyProteomics platforms and consumables (SomaScan, CyTOF, Hyperion),Genomics platforms and consumables (Biomark X9 and related systems),Services, software, and other,
      OXFORD NANOPORE TECHNOLOGIES PLCUnited KingdomPublic CompanyMinION and portable platforms (incl. Mk 1D),GridION / GridION Q benchtop systems,PromethION (P2, P24, P48) high-throughput,
      GENSCRIPTHong KongPublic CompanyLife Science Services and Products,Biologics Development Services,Industrial Synthetic Biology Products,
      TAKARA BIO INC.JapanPrivate CompanyGenetic and cellular research reagents,PCR instruments and cellular analysis devices,In vitro diagnostics (including COVID-19 testing),

      ATS AUTOMATION TOOLING SYSTEMS INC

      ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems.

      DECODE GENETICS

      Decode Genetics is a private Icelandic company founded in 1996 with 331 employees. The company operates in the genetics and genomics sector.

      GENOMIC HEALTH INC

      Genomic Health Inc. is a private United States company founded in 2000 with 829 employees. The company focuses on genomic testing and personalized medicine.

      TRANSGENOMIC, INC.

      Transgenomic, Inc. is a public United States company founded in 1997 with 19 employees. The company operates in the genomics and molecular diagnostics field.

      UNILABS

      Unilabs is a private Swiss company founded in 1987 with 1,897 employees. The company provides laboratory and diagnostic services.

      MAXCYTE, INC

      MaxCyte, Inc. is a public United States company founded in 1998 with 91 employees. The company develops cell engineering technologies.

      GENERAL ELECTRIC

      General Electric is a public United States company founded in 1892 with 57,000 employees. The company operates across multiple industrial and technology sectors.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a public United States company founded in 1956 with 125,000 employees. The company is a global leader in life sciences, analytical instruments, and laboratory services.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a public United States company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.

      ILLUMINA, INC.

      Illumina, Inc. is a public United States company founded in 1998 with 8,625 employees. The company is a leading provider of DNA sequencing and genetic analysis technologies.

      QIAGEN

      QIAGEN is a public company founded in 1984 in the Netherlands with 5,500 employees. The company develops and manufactures molecular diagnostics and life sciences products.

      REVVITY

      Revvity is a public United States company founded in 1937 with 11,000 employees. The company provides analytical instruments, software, and services for research and diagnostics.

      PACBIO

      PacBio is a public United States company founded in 2000 with 485 employees. The company develops long-read DNA sequencing technologies.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a public United States company founded in 1999 with 18,000 employees. The company manufactures analytical instruments, software, and services for life sciences and diagnostics.

      SYSMEX CORPORATION

      Sysmex Corporation is a public Japanese company founded in 1968 with 10,861 employees. The company manufactures and sells in vitro diagnostic systems and laboratory instruments.

      EUROFINS SCIENTIFIC

      Eurofins Scientific is a public company founded in 1987 in Luxembourg with 65,694 employees. The company is a leading provider of laboratory testing and analytical services globally.

      STANDARD BIOTOOLS

      Standard Biotools is a public United States company founded in 1999 with 387 employees. The company develops microfluidics and cell analysis technologies.

      OXFORD NANOPORE TECHNOLOGIES PLC

      Oxford Nanopore Technologies PLC is a public United Kingdom company founded in 2005 with 1,316 employees. The company develops nanopore-based DNA and RNA sequencing technologies.

      GENSCRIPT

      GenScript is a public company founded in 2002 in Hong Kong with 6,165 employees. The company provides biotechnology research services and products including gene synthesis and protein production.

      TAKARA BIO INC.

      Takara Bio Inc. is a private Japanese company founded in 2002 with 1,779 employees. The company manufactures and sells molecular biology reagents and research products.

      Reasons to Buy this Report

      • Japan-Specific Market Sizing : Obtain precise valuation data for Japan's gene expression analysis market with detailed 2026-2031 forecasts, enabling accurate business planning and investment decisions tailored to this high-value Asian market.
      • Competitive Landscape Intelligence : Understand the competitive dynamics specific to Japan's healthcare sector, including local and international players, market share distribution, and strategic positioning within Japan's regulated environment.
      • Regulatory & Reimbursement Insights : Access Japan-specific regulatory requirements, reimbursement policies, and healthcare system dynamics that directly impact market entry strategies and commercial viability for gene expression solutions.
      • Growth Driver Analysis : Identify Japan-specific growth catalysts including demographic trends, disease prevalence patterns, healthcare infrastructure investments, and government precision medicine initiatives shaping market expansion.
      • Strategic Market Entry Planning : Leverage Japan market data to develop targeted go-to-market strategies, identify partnership opportunities with Japanese healthcare institutions, and optimize resource allocation for regional expansion.

      Frequently asked questions

      What is the current size of Japan's gene expression analysis market?

      Japan's gene expression analysis market is valued at $123.0 million in 2026 and is expected to grow to $184.7 million by 2031.

      What is the projected growth rate for Japan's gene expression analysis market?

      Japan's gene expression analysis market is projected to grow at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2031.

      What factors are driving growth in Japan's gene expression analysis market?

      Key drivers include Japan's aging population, rising cancer prevalence, advanced healthcare infrastructure, government support for genomic research, and increasing adoption of precision medicine.

      How does Japan's market compare to other Asia Pacific countries?

      Japan is positioned as a leading market in Asia Pacific for gene expression analysis, supported by strong healthcare systems, regulatory frameworks, and investment in biotechnology innovation.

      What applications are most prevalent in Japan's gene expression analysis market?

      Primary applications in Japan include cancer diagnostics, genetic disorder screening, personalized medicine, and research applications in academic and clinical settings.

      RESEARCH METHODOLOGY

      This research study extensively utilized secondary sources, directories, and databases to identify and collect valuable information for analyzing the global gene expression analysis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was triangulated with inputs from primary research to determine the final market size.

      Secondary Research

      Secondary research was primarily used to identify and collect information for the comprehensive technical, market-oriented, and commercial study of the gene expression analysis market. The secondary sources used for this study include World Health Organization (WHO), Food and Drug Administration (FDA), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Environmental Protection Agency (EPA), European Medicines Agency (EMA), Biotechnology Innovation Organization (BIO), International Society for Pharmaceutical Engineering (ISPE), National Institute for Health and Care Excellence (NICE), World National Center for Biotechnology Information (NCBI), International Trade Centre, Journal of Molecular Biology, Journal of Biological Chemistry (JBC), American Association for Cancer Research (AACR), the American Society of Human Genetics (ASHG), and the European Molecular Biology Organization (EMBO). Academic Journals and Company Websites, corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations, among others.

      Secondary data were collected and analyzed to determine the overall size of the global gene expression analysis market, which was subsequently validated through primary research. These sources were also used to gather key information about major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technological perspectives.

      Primary Research

      In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

      Gene Expression Analysis Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The top-down and bottom-up approaches were used to estimate & validate the total size of the gene expression analysis market. These methods were also used extensively to estimate the size of various market segments.

      Gene Expression Analysis Market : Top-Down and Bottom-Up Approach

      Gene Expression Analysis Market Top Down and Bottom Up Approach

      Data Triangulation

      After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from the demand and supply sides.

      Market Definition

      Gene expression analysis is the systematic investigation of the activity levels of genes within a cell, tissue, or organism at a specific point in time, which involves measuring & quantifying the production of RNA or protein molecules encoded by genes that reflect the degree to which genes are being transcribed and translated into functional products. In gene expression analysis, we use products & services related to the analysis and measurement of gene expression. This market includes gene expression analysis products & services such as reagents & consumables, instruments, gene expression analysis services, and bioinformatics solutions.

      Key Stakeholders

      • Pharmaceutical & biotechnology companies
      • Contract research organizations (CROs)
      • Life science companies
      • Academic & research institutes
      • Private research institutes
      • Venture capitalists & investors
      • Market research & consulting firms
      • Government associations
      • Medical institutions & universities
      • Hospitals & clinics

      Report Objectives

      • To define, describe, and forecast the gene expression analysis market based on offering, application, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall gene expression analysis market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
      • To strategically profile the key players in the gene expression analysis market and comprehensively analyze their core competencies and market rankings
      • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the gene expression analysis market
      • To benchmark players within the gene expression analysis market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy

      Customization Options

      With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

      Geographical Analysis

      • Further breakdown of the Rest of Europe gene expression analysis market, by country
      • Further breakdown of the Rest of Asia Pacific gene expression analysis market, by country
      • Further breakdown of the Rest of Latin America gene expression analysis market, by country
      • Further breakdown of the Rest of Middle East gene expression analysis market, by country

      Company Information

      • Detailed analysis and profiling of additional market players (up to five)

      Get the Full Gene Expression Analysis Market Report

      Full forecast, segment splits, and company analysis for all Gene Expression Analysis Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status